Intensive glucose lowering in cardiovascular risk management - unsolved questions -

MeSH terms

• Coronary Artery Disease / prevention & control*
• Cyclohexanes / pharmacology*
• Diabetes Mellitus / drug therapy*
• Female
• Glycemic Index / drug effects*
• Humans
• Inositol / analogs & derivatives*
• Inositol / pharmacology
• Male
• Nateglinide
• Phenylalanine / analogs & derivatives*
• Phenylalanine / pharmacology